AQR Arbitrage’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

AQR Arbitrage’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-130,779	Closed	-$1.31M	–	716
2023 Q4	$1.31M	Buy	+130,779	New	+$593K	0.05%	288

AQR Arbitrage's GRCL Position: Q1 2024 in Review

AQR Arbitrage sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 130,779 shares — an estimated $1.31M sold.

AQR Arbitrage first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $1.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

AQR Arbitrage reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
AQR Arbitrage sold 130,779 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $1.31M.
AQR Arbitrage first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
AQR Arbitrage's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.31M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on AQR Arbitrage's 13F filing for Q1 2024, filed 15 May 2024.